Intuitive Surgical Inc (NASDAQ:), a pacesetter in robotic-assisted surgical procedure, noticed its shares leap greater than 6% after reporting third-quarter earnings that surpassed analyst expectations. The corporate’s robust efficiency was pushed by elevated adoption of its da Vinci surgical programs and progress in process volumes.
For the quarter ended September 30, Intuitive Surgical reported adjusted earnings per share of $1.84, beating the analyst consensus of $1.64 by $0.20. Income got here in at $2.04 billion, exceeding the estimated $2.01 billion and marking a 17% improve from $1.74 billion in the identical quarter final 12 months.
The corporate’s da Vinci procedures grew roughly 18% YoY, whereas system placements elevated to 379 models, up from 312 within the third quarter of 2023. Notably, 110 of those placements have been the brand new da Vinci 5 programs. Intuitive’s put in base of da Vinci programs reached 9,539, a 15% YoY improve.
Devices and equipment income, a key indicator of surgical exercise, rose 18% to $1.26 billion. Methods income additionally noticed progress, reaching $445 million in comparison with $379 million within the prior-year quarter.
Gary Guthart, Intuitive’s CEO, commented on the outcomes: “Core measures of our business were healthy this quarter, and we are pleased by customer adoption of da Vinci 5. We remain focused on delivering the goals we share with our customers, centered on improving patient outcomes.”
The corporate’s robust monetary place was underscored by its money, money equivalents, and investments steadiness of $8.31 billion on the quarter’s finish, a rise of $628 million in the course of the interval.
Jefferies analysts lifted their ISRG estimates and the price goal (PT) following the report.
“This was a solid quarter with healthy procedure and capital trends and high DV5 interest,” they commented.
The price goal was hiked from $415 to $475, though the agency maintained a Maintain ranking primarily based on valuation.
Individually, Bernstein analysts famous that whereas da Vinci 5 stays in restricted launch by mid-2025, “the pace of progress is very encouraging.”
The funding financial institution reiterated Intuitive Surgical as its high choose and raised the goal price from $525 to $585.
Senad Karaahmetovic contributed to this report.